The information in this website contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended, on Theriva™ Biologics’ current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “could, ” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the timing and results of our clinical trials and our ability to successfully develop products with superior benefits. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Theriva Biologics’ forward-looking statements include, among others, the availability of financial and other resources and the allocation of resources among different potential uses, a failure of our clinical trials to be completed on time or to achieve desired results, or failure by us or our strategic partners to successfully commercialize products and other factors described in greater detail on Theriva Biologics’ report on Form 10-K and other filings with the SEC, which are available at www.sec.gov. As with all material posted on this website, such forward-looking statements are current as of the date posted, and Theriva Biologics expressly disclaims any obligation to update such statements.
All statements and expressions are the sole opinion of the Company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained.
Links to third party pages are provided for convenience only. Theriva Biologics does not express any opinion on the content of any third party pages and expressly disclaims any liability for all third party information and the use of such information. Investors are cautioned that they may lose all or a portion of their investment in this or any other company.